Related Experiment Video
Updated: Aug 16, 2025

Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches
Tanzeel Khan1, Rashid Waseem1, Zainy Zehra1
1Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi 110025, India.
Mitochondrial dysfunction contributes to various diseases. Novel nanoformulations offer promising strategies for mitochondria-targeted drug delivery to treat these conditions effectively.
Area of Science:
- Cell Biology
- Biochemistry
- Nanotechnology
Background:
- Mitochondria are vital organelles for cellular function beyond ATP generation.
- Mitochondrial dysfunction is linked to numerous pathologies, including metabolic disorders, cancer, and neurodegenerative diseases.
- Targeting mitochondria presents a promising therapeutic avenue for disease treatment and prevention.
Purpose of the Study:
- To review the role of mitochondrial dysfunction in disease pathophysiology.
- To discuss recent advancements in mitochondria-targeted drug delivery strategies.
- To highlight the challenges and potential of nanoformulations for mitochondrial therapy.
Main Methods:
- Review of scientific literature on mitochondrial dysfunction and drug delivery.
- Analysis of various nanoformulation strategies for targeting mitochondria.
- Discussion of mitochondriotropic moieties and their role in drug delivery.
Main Results:
- Mitochondrial dysfunction is a significant factor in various human diseases.
- Nanoformulations, including nanoparticles and liposomes, are being developed for mitochondria-targeted therapy.
- Mitochondriotropic moieties like MPPs, TPP, and DQA facilitate drug delivery into mitochondria.
Conclusions:
- Mitochondria-targeted drug delivery is crucial for treating diseases associated with mitochondrial dysfunction.
- Advancements in nanotechnology offer effective solutions to overcome mitochondrial barriers.
- Further research into nanoformulations holds significant therapeutic potential.
More Related Videos
08:15Exploring Mitochondrial Energy Metabolism of Single 3D Microtissue Spheroids Using Extracellular Flux Analysis
Published on: February 3, 2022
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Membranes
Mitochondria
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
ATP Synthase: Mechanism